---
category: news
title: "Tempus Announces Companion Diagnostic Collaboration With A2 Biotherapeutics"
excerpt: "Tempus, a leader in artificial intelligence and precision medicine, today announced a strategic collaboration to develop a companion diagnostic (CDx) test with A2 Biotherapeutics for its new therapy targeting patients with Loss of Heterozygosity (LOH)."
publishedDateTime: 2021-01-13T19:20:00Z
originalUrl: "https://apnews.com/press-release/business-wire/technology-medical-technology-tumors-diagnosis-and-treatment-health-bbd2bb37dd7b452b9f4f809dc702faf9"
webUrl: "https://apnews.com/press-release/business-wire/technology-medical-technology-tumors-diagnosis-and-treatment-health-bbd2bb37dd7b452b9f4f809dc702faf9"
type: article

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "kp6a0sRFgT833CtCXNK9wgd8IYoX2NkVPCL/fDFqXkBQT7htdQf7UobkwOONJ0IXc0KOt3lFwhwujFNAdFOit6X6Dp96fyFOU9k+TJD0E3R5pwZmRFw8raLoh4p86fLEagDBGLgaUALHLlm1A+EdLd6iJk0AB4w4Cmq6epVALs2C7eOxoEba2TrsE9NvVvu7WDWP2QmBRBMv7DwcRRkoZYwaMwNjfIZ8il1Rh3uwKnxV4NkQ2qfBJb1PmDOkyy8GbG/72juADzM6FbHCRrjm48Q+revATF2cpdxXSjgWCi4Kf4nLxWJsYBCREd/lDzL1J6VmN+qn1T3U95BM2GHxxnvafcDqobQ6stgYwmehutg=;E/YkNWFxQZvTl2uRHiegGg=="
---

